Year To Quarter End Consolidated Statement Of Income

Modalis Therapeutics Corporation - Filing #7609137

Concept 2022-01-01 to
2022-03-31
2021-01-01 to
2021-03-31
Year to quarter end consolidated statement of income
Statement of income
Selling, general and administrative expenses
Selling, general and administrative expenses
64,979,000 JPY
69,053,000 JPY
Operating profit (loss)
-466,718,000 JPY
-252,636,000 JPY
Non-operating income
Interest income
27,000 JPY
27,000 JPY
Non-operating income
24,481,000 JPY
7,223,000 JPY
Non-operating expenses
Interest expenses
1,119,000 JPY
JPY
Non-operating expenses
1,466,000 JPY
397,000 JPY
Ordinary profit (loss)
-443,703,000 JPY
-245,810,000 JPY
Extraordinary income
Extraordinary income
JPY
485,881,000 JPY
Profit (loss) before income taxes
-443,703,000 JPY
240,071,000 JPY
Income taxes - current
306,000 JPY
36,153,000 JPY
Income taxes - deferred
-5,103,000 JPY
2,118,000 JPY
Income taxes
-4,797,000 JPY
38,271,000 JPY
Profit (loss)
-438,906,000 JPY
201,800,000 JPY
Profit attributable to
Profit (loss) attributable to owners of parent
-438,906,000 JPY
201,800,000 JPY
Other comprehensive income
Foreign currency translation adjustment
11,422,000 JPY
8,203,000 JPY
Other comprehensive income
11,422,000 JPY
8,203,000 JPY
Comprehensive income
-427,484,000 JPY
210,004,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-427,484,000 JPY
210,004,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.